Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Sell

Debt to Equity Rating

Neutral

Price to Earnings Rating

Sell

Analyst Rating

Neutral

Aura Biosciences, Inc. Common Stock (AURA)

Biological Products, (no Disgnostic Substances)

https://www.aurabiosciences.com

Aura Biosciences Inc is a clinical-stage oncology company developing a novel technology platform based on virus-like drug conjugates to target and destroy cancer cells selectively while activating the immune system to create long-lasting anti-tumor immunity.

80 GUEST STREET
BOSTON, MA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

10/29/2021

Market Cap

391,228,656

Shares Outstanding

49,200,000

Weighted SO

49,259,879

Total Employees

N/A

Upcoming Earnings

N/A

Beta

0.3920

Last Div

0.0000

Range

5.99-12.35

Chg

-0.2833

Avg Vol

204196

Mkt Cap

391228656

Exch

NASDAQ

Country

US

Phone

617 500 8864

DCF Diff

7.3167

DCF

0.5433

Div Yield

0.0000

P/S

190.2863

EV Multiple

-4.3486

P/FV

2.0437

Div Yield %

0.0000

P/E

-4.8493

PEG

4.6310

Payout

0.0000

Current Ratio

18.5434

Quick Ratio

18.5434

Cash Ratio

2.8513

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

396.5264

CCC

-396.5264

Gross Margin

0.3468

Op Margin

-42.9815

Pretax Margin

-39.1552

Net Margin

-39.2442

Eff Tax Rate

0.0020

ROA

-0.3696

ROE

-0.4149

ROCE

-0.4254

NI/EBT

1.0023

EBT/EBIT

0.9110

EBIT/Rev

-42.9815

Debt Ratio

0.0872

D/E

0.0994

LT Debt/Cap

0.0784

Total Debt/Cap

0.0904

Int Coverage

-38.3218

CF/Debt

-3.8547

Equity Multi

1.1401

Rec Turnover

0.0000

Pay Turnover

0.9205

Inv Turnover

0.0000

FA Turnover

0.0957

Asset Turnover

0.0094

OCF/Share

-1.4808

FCF/Share

-1.5014

Cash/Share

3.7825

OCF/Sales

-35.6858

FCF/OCF

1.0139

CF Coverage

-3.8547

ST Coverage

-26.6412

CapEx Coverage

-71.9314

Div&CapEx Cov

-71.9314

P/BV

2.0437

P/B

2.0437

P/S

190.2863

P/E

-4.8493

P/FCF

-5.2592

P/OCF

-5.3328

P/CF

-5.3328

PEG

4.6310

P/S

190.2863

EV Multiple

-4.3486

P/FV

2.0437

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation